PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30017881-0	2018	The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6.	Zonisamide	27-37	sodium channel, voltage-gated, type VIII, alpha	Mus musculus	84-91	
30017881-8	2018	Together, these findings suggest that zonisamide may reduce neuroinflammation through the down-regulation of microglial Nav 1.6.	Zonisamide	38-48	sodium channel, voltage-gated, type VIII, alpha	Mus musculus	120-127	
30017881-9	2018	Thus, in addition to its effects on parkinsonian symptoms through inhibition of MAO-B, zonisamide may have disease modifying potential through the inhibition of Nav 1.6 and neuroinflammation.	Zonisamide	87-97	sodium channel, voltage-gated, type VIII, alpha	Mus musculus	161-168